BridgeBio Pharma Inc (NASDAQ:BBIO)
| 49.36 Delayed Data As of 4:05pm ET |  +0.91 / +1.88%Today’s Change | 36.20 Today|||52-Week Range 73.50 | -30.59% Year-to-Date |
Latest BBIO News | Press Releases
No recent news for BridgeBio Pharma Inc.
Today’s Trading
| Previous close | 48.45 |
| Today’s open | 48.25 |
| Day’s range | 47.10 - 49.36 |
| Volume | 18,323 |
| Average volume (3 months) | 846,352 |
| Market cap | $7.6B |
Data as of 4:05pm ET, 09/16/2021
Growth & Valuation
| Earnings growth (last year) | -53.38% |
| Earnings growth (this year) | +6.11% |
| Earnings growth (next 5 years) | -56.93% |
| Revenue growth (last year) | -79.66% |
| P/E ratio | NM |
| Price/Sales | 1,017.17 |
| Price/Book | 106.99 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TEVATeva Pharmaceutical | -0.05 | -0.56% |
| ---- | ||
| IMMBImmunotech Laborator... | +0.00 | +400.00% |
| BGNEBeigene Ltd | +10.45 | +2.79% |
Data as of 5:43pm ET, 09/16/2021
Financials
| Next reporting date | November 11, 2021 |
| EPS forecast (this quarter) | -$0.87 |
| Annual revenue (last year) | $8.2M |
| Annual profit (last year) | -$448.7M |
| Net profit margin | -5,439.74% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Palo Alto, California |
Forecasts
